Brian Corvese - Sep 9, 2025 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
INKT
Transactions as of
Sep 9, 2025
Transactions value $
$0
Form type
4
Date filed
9/11/2025, 04:05 PM
Previous filing
Sep 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Corvese Brian Director 149 FIFTH AVENUE, SUITE 500, NEW YORK By: /s/ Christine Klaskin, Attorney-in-Fact 2025-09-11 0001393207

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INKT Stock Option (Right to Buy) Award $0 +3.23K $0.00 3.23K Sep 9, 2025 Common Stock 3.23K $15.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.